Success Story: Advancing AI-Integrated Neuroimaging for Precision Healthcare: NIW Approval Secured for a Radiology Researcher from Turkey
Client’s Testimonial:
"I am sincerely grateful to the Chen Immigration Team for their exceptional support throughout my EB-2 NIW petition process. They prepared a highly organized and persuasive petition that accurately presented my research contributions in radiology and advanced neuroimaging. The team was professional, responsive, and detail-oriented at every stage of the process. I am very pleased that my I-140 NIW petition was approved."
On July 29th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Radiology Resident Physician in the field of Radiology (Approval Notice).
General Field: Radiology
Position at the Time of Case Filing: Radiology Resident Physician
Country of Origin: Turkey
Country of Residence at the Time of Filing: Turkey
Approval Notice Date: July 29th, 2026
Processing Time: 11 months, 25 days (Premium Processing Requested)
Case Summary:
We are pleased to share the NIW approval of a radiology resident and researcher whose work advances the integration of artificial intelligence with advanced neuroimaging to improve the diagnosis and management of neurological disorders. The client’s research focuses on developing and applying advanced neuroimaging techniques, including AI-assisted approaches, to enhance clinical neuroradiology workflows for conditions such as gliomas, post-COVID neurological syndromes, and immune-mediated central nervous system diseases. At the time of filing, the client was a Radiology Resident Physician, where he continued conducting research on advanced imaging methods and AI-driven tools to support more precise diagnosis, treatment planning, and disease monitoring.
Research Significance
The client’s research addresses important challenges in neurological healthcare by improving the ability to characterize brain disorders and extract meaningful insights from medical imaging data. By integrating AI with multimodal neuroimaging techniques, his work enables more accurate assessment of disease progression, supports personalized treatment strategies, and strengthens clinical decision-making for neurological conditions. These contributions align with U.S. priorities in precision medicine, responsible AI applications, and improving public health outcomes through advanced healthcare technologies.
Academic Contributions and Recognition
At the time of filing, the client’s record included 5 peer-reviewed journal articles (1 first-authored) and 1 conference abstract, which collectively received 93 citations. His research contributions include evaluating advanced magnetic resonance imaging techniques, identifying non-invasive imaging biomarkers, and investigating imaging approaches for neurological disorders, including gliomas and post-COVID neurological changes.
His work has been recognized by independent researchers, with one publication ranking among the top 10% most cited articles in Clinical Medicine for its publication year. Researchers have also applied his findings to advance studies involving post-COVID neurological symptoms, glioma imaging assessment, and vaccine-related immune response evaluation. These achievements demonstrate the influence of his research and his ability to contribute meaningful advances in radiology and neuroimaging.
Recognition from Experts
Experts highlighted the client’s research expertise and potential contributions to advancing neuroradiology through AI-integrated imaging approaches.
One expert noted:
“Based on his demonstrated research productivity, technical expertise, and clinical orientation, I believe [client] is exceptionally well-positioned to contribute to the advancement of neuroradiology in the United States.”
This endorsement reinforces the client’s strong foundation in radiology research and his potential to advance AI-integrated neuroimaging approaches. Combined with his publication record, citation impact, and documented influence on subsequent research, the expert recognition further demonstrates his ability to contribute meaningful advances in neuroradiology.
NIW Approval and Outlook
The I-140 NIW petition was filed on August 4th, 2025, later upgraded to Premium Processing, and approved on July 29th, 2026. The approval recognized the national importance of the client’s work in radiology, particularly his efforts to develop AI-integrated neuroimaging approaches that improve diagnosis, treatment planning, and long-term monitoring of neurological and autoimmune disorders.
This outcome supports the client’s continued efforts to advance precision healthcare, AI-assisted radiology workflows, and innovative neuroimaging solutions in the United States. We congratulate him on this approval and wish him continued success in contributing to the advancement of medical imaging and healthcare technology.